Expert Speaker Faculty

Take a look at the esteemed speaker faculty for the  14th Alzheimer’s & Parkinson’s Drug Development Summit.

Pharma Expert Speakers
Biotech Expert Speakers
Academic Thought Leaders, Investor Voices & Patient Advocates

Pharma Expert Speakers

Ross Jeggo, Head of Neurology Research, Biogen - 14th Alzheimers & Parkinsons Drug Development Summit

Ross Jeggo

Head of Neurology Research
Biogen
Jessica Wu, Scientific Director, Biogen - 14th Alzheimer's & Parkinson's Drug Development Summit

Jessica Wu

Scientific Director
Biogen
Achim Kless, Senior Director, Discovery Neuroscience Research, Neuroscience Genetics, Eli Lilly & Co. - 14th Alzheimer's & Parkinson's Drug Development Summit

Achim Kless, PhD

Senior Director, Discovery Neuroscience Research, Neuroscience Genetics
Eli Lilly & Co.
Dimitry Ofengeim, Senior Scientist, Head, of Distinguished, Neuroinflammation & Precision Neurology Group, Sanofi - 14th Alzheimer's & Parkinson's Drug Development Summit

Dimitry Ofengeim

Senior Scientist, Head, of Distinguished, Neuroinflammation & Precision Neurology Group
Sanofi
Gennaro Pagano, Group Leader and Expert Medical Director In Early Development, Roche - 14th Alzheimer's & Parkinson's Drug Development Summit

Gennaro Pagano

Group Leader and Expert Medical Director In Early Development
Roche
Nellwyn Hagan, Scientific Director Neurodegenerative Disorders, Takeda - 14th Alzheimer's & Parkinson's Drug Development Summit

Nellwyn Hagan

Scientific Director Neurodegenerative Disorders
Takeda Pharmaceutical
Gyan Srivastava, Associate Director & Head Of Computational Biology, Alexion Pharma UK - 14th Alzheimer's & Parkinson's Drug Development Summit

Gyan Srivastava

Associate Director & Head Of Computational Biology
Alexion Pharma UK

Malleswari Challagundla

Senior Scientist II
Abbvie
Laura Cohen, Vice President, Alzheimer's Environment Shaping, Lilly Neuroscience, Eli Lilly & Co. - 14th Alzheimer's & Parkinson's Drug Development Summit

Laura Cohen

Vice President, Alzheimer's Environment Shaping
Eli Lilly & Co.
Abigail Mariga, Senior Principal Scientist, Bristol Myers Squibb - 14th Alzheimer's & Parkinson's Drug Development Summit

Abigail Mariga

Senior Principal Scientist
Bristol Myers Squibb
Nima Shariati, Project Statistician & Data Science Team Lead, Roche- 14th Alzheimer's & Parkinson's Drug Development Summit

Nima Shariati

Project Statistician & Data Science Team Lead
Roche
Danielle Graham, Vice President & Head of Biomarkers, Biogen - 14th Alzheimer's & Parkinson's Drug Development Summit

Danielle Graham

Vice President & Head of Biomarkers
Biogen
Roman Loonis, Associate Medical Director, Clinical Sciences, Neurodegenerative Disorders, Takeda - 14th Alzheimers & Parkinsons Drug Development Summit

Roman Loonis

Associate Medical Director, Clinical Sciences, Neurodegenerative Disorders
Takeda Pharmaceutical

Biotech Expert Speakers

Eric Siemers, Chief Medical Officer, Acumen - 14th Alzheimer's & Parkinson's Drug Development Summit

Eric Siemers

Chief Medical Officer
Acumen Pharmaceuticals
Kira Holmstrom, Head of Biomarker Research, Herantis - 14th Alzheimer's & Parkinson's Drug Development Summit

Kira Holmström

Head of Biomarker Research
Herantis
Bruce Morimoto, Head, Drug Development, Fuku Biotech - 14th Alzheimer's & Parkinson's Drug Development Summit

Bruce Morimoto

head drug dev
Fuku Biotech
Lili Zhang, SVP, Head of Preclinical Development, Aprinoia Therapeutics Inc. - 14th Alzheimer's & Parkinson's Drug Development Summit

Lili Zhang

Senior Vice President, Head of Preclinical Development
Aprinoia Therapeutics Inc.
14th Alzheimers & Parkinsons Drug Development Summit

Paul Gregor

Chief Executive Officer
Gismo Therapeutics Inc.
Raj Rajagovindan, Vice President - Translational Medicine, Voyager Therapeutics, Inc- 14th Alzheimers & Parkinsons Drug Development Summit

Raj Rajagovindan

Vice President - Translational Medicine
Voyager Therapeutics, Inc
Paul Ashton, President & Chief Executive Officer, Inflammasome Therapeutics - 14th Alzheimer's & Parkinson's Drug Development Summit

Paul Ashton

President & Chief Executive Officer
Inflammasome Therapeutics
Susan Abushakra, Chief Medical Officer, Alzheon - 14th Alzheimers & Parkinsons Drug Development Summit

Susan Abushakra

Chief Medical Officer
Alzheon
Jennifer Johnston, Co-Founder & Chief Executive Officer, NysnoBio - 14th Alzheimer's & Parkinson's Drug Development Summit

Jennifer Johnston

Co-Founder & Chief Executive Officer
NysnoBio
Marianthi Papakosta, Director, Neuroscience Research, Neurocrine Biosciences - 14th Alzheimer's & Parkinson's Drug Development Summit

Marianthi Papakosta

Director, Neuroscience Research
Neurocrine Biosciences
Patrick Kesslak, Senior Research Fellow, Alzheon - 14th Alzheimer's & Parkinson's Drug Development Summit

J Patrick Kesslak Kesslak

Senior Research Fellow
Alzheon
Sathya Ganesan, Director, Global Regulatory Affairs, UCB - 14th Alzheimers & Parkinsons Drug Development Summit

Sathya Ganesan

Director, Global Regulatory Affairs
UCB
Yongchang Qiu, Founder & CEO, Lysoway Therapeutics - 14th Alzheimers & Parkinsons Drug Development Summit

Yongchang Qiu

Founder & Chief Executive Officer
Lysoway Therapeutics
Karen Quadrini, Director - Clinical Biomarkers, Prothena Corporation - 14th Alzheimer's & Parkinson's Drug Development Summit

Karen Quadrini

Director, Clinical Biomarkers
Prothena Corporation

Academic Thought Leaders, Investor Voices & Patient Advocates

Malu Tansey, Director of Neuroimmunology Research & Executive Associate Director of Education Stark Neuroscience Research Institute, Indiana University School of Medicine - 14th Alzheimer's & Parkinson's Drug Development Summit

Malú Tansey

Director of Neuroimmunology Research & Executive Associate Director of Education Stark Neuroscience Research Institute
Indiana University School of Medicine
Alexander Shtilbans, Assistant Professor - Neurology, Cornell University - 14th Alzheimer's & Parkinson's Drug Development Summit

Alexander Shtilbans

Director of Movement Disorder Program, HSS, Hospital for Special Surgery; Assistant Professor of Neurology
Cornell University
Pardeep Pabla - 14th Alzheimer's & Parkinson's Drug Development Summit

Pardeep Pabla

Manager
Living with Parkinson's Disease
Tharick Pascoal, Assistant Professor, UPitt- 14th Alzheimers & Parkinsons Drug Development Summit

Tharick A Pascoal

Assistant Professor
UPitt
Mira Chaurushiya, Managing Director Westlake Village BioPartners - 14th Alzheimers & Parkinsons Drug Development Summit

Mira Chaurushiya

Managing Director
Westlake Village BioPartners
Manik Kuchroo, Investor, Polaris Partners Ltd - 14th Alzheimer's & Parkinson's Drug Development Summit

Manik Kuchroo

Investor
Polaris Partners Ltd
Brendan Hussey, Vice President JLS Fund- 14th Alzheimers & Parkinsons Drug Development Summit

Brendan Hussey

Vice President
JLS Fund
Fernanda Cerqueira, Senior Associate Director - Research Programs & Translational, The Michael J. Fox Foundation for Parkinson's Research - 14th Alzheimers & Parkinsons Drug Development Summit

Fernanda Cerqueira

Senior Associate Director - Research Programs & Translational
The Michael J. Fox Foundation for Parkinson's Research
Explore the Agenda - 14th Alzheimers & Parkinsons Drug Development Summit
Explore the Agenda

Hear the latest industry breakthroughs and gain exclusive regulatory insights during 3 jam-packed days of interactive workshops, roundtables, panel discussions and data driven content.

View Presentations & Speakers
Partner With Us - 14th Alzheimers & Parkinsons Drug Development Summit
Partner With Us

Position yourself alongside other leading solution providers.

Explore Sponsorship Options
Join Biopharma Experts - 14th Alzheimers & Parkinsons Drug Development Summit
Join Biopharma Experts

Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.

Register Now